Indivior Announces FDA Grants Priority Review For SUBLOCADE Prior Approval Supplement
8/10 02:57
(RTTNews) - Indivior Plc.(INDV) announced that the U.S. Food and Drug Administration has granted Priority Review designation for the Prior Approval Supplement of SUBLOCADE (buprenorphine extended-release) injection, which was submitted by Indivior, Inc. The Prescription Drug User...